{"title":"妊娠期左乙拉西坦所致出生缺陷1例报告","authors":"Mukul Pandey, P. Batra","doi":"10.54136/erwej-0101-10006","DOIUrl":null,"url":null,"abstract":"There is a lack of substantial data on the safety of Levetiracetam during pregnancy in the context of the potential teratogenic effect on the newborn. We report a probable case of levetiracetam birth defects in a newborn with multiple congenital anomalies.","PeriodicalId":312076,"journal":{"name":"Exclusive Real World Evidence Journal","volume":"48 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Birth Defects following Levetiracetam Use in Pregnancy – A Case Report\",\"authors\":\"Mukul Pandey, P. Batra\",\"doi\":\"10.54136/erwej-0101-10006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"There is a lack of substantial data on the safety of Levetiracetam during pregnancy in the context of the potential teratogenic effect on the newborn. We report a probable case of levetiracetam birth defects in a newborn with multiple congenital anomalies.\",\"PeriodicalId\":312076,\"journal\":{\"name\":\"Exclusive Real World Evidence Journal\",\"volume\":\"48 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Exclusive Real World Evidence Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.54136/erwej-0101-10006\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exclusive Real World Evidence Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54136/erwej-0101-10006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Birth Defects following Levetiracetam Use in Pregnancy – A Case Report
There is a lack of substantial data on the safety of Levetiracetam during pregnancy in the context of the potential teratogenic effect on the newborn. We report a probable case of levetiracetam birth defects in a newborn with multiple congenital anomalies.